Breast Cancer Clinical Trial

A Lifestyle Intervention for Breast Cancer Survivors

Summary

The purpose of the study is to test the effectiveness of a new mail-based intervention for breast cancer survivors compared with standard lifestyle management and no-treatment.
This intervention addresses both lifestyle factors such as dietary and physical activities and psychological issues specific to breast cancer survivors to improve healthy behaviors.

View Full Description

Full Description

Participants will be assigned randomly to one of three groups: 1) newly developed mail-based intervention (Targeting the Teachable Moment Intervention; TTMI), 2) standard Lifestyle Intervention (SLM), and 3) usual care. Both TTMI and SLM focus on health behaviors, however TTMI additionally addresses psychosocial issues specific to breast cancer survivors.

All participants will complete questionnaires at the time they start the study, the end of the 4 months, and 3 months later for a follow-up.

If participants are assigned to any of the intervention group, they will receive materials every other week for 4 months. If participants are assigned to the usual care group, they will receive the same materials as the standard lifestyle intervention et the end of the 7 months.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

First diagnosed with breast cancer in the past 1.5 years
stage 0~2 breast cancer
no prior adjuvant treatment for another cancer
Can read and write English
Are not participating in other health behavior research right now

Exclusion Criteria:

apparent serious mental disturbance
male breast cancer survivors

Study is for people with:

Breast Cancer

Estimated Enrollment:

173

Study ID:

NCT01819324

Recruitment Status:

Completed

Sponsor:

Hartford Hospital

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Connecticut
Storrs Connecticut, 06269, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

173

Study ID:

NCT01819324

Recruitment Status:

Completed

Sponsor:


Hartford Hospital

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.